STOCK TITAN
  1. Home
  2. Sec-filings
  3. ENTX
  4. [Form 4] Entera Bio Ltd. Insider Trading Activity

Entera Bio (ENTX) CFO receives 58,394 RSUs through A2Z Counseling Ltd.

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Yaacov-Garbeli Dana reported acquisition or exercise transactions in this Form 4 filing.

Entera Bio Ltd. granted 58,394 stock-settled restricted stock units tied to its ordinary shares to A2Z Counseling Ltd., an entity associated with Chief Financial Officer Dana Yaacov-Garbeli, as compensation in lieu of a cash bonus. The units vest quarterly over a one-year period that began on May 1, 2026.

Following this award, A2Z Counseling Ltd. held 171,441 ordinary shares indirectly for the reporting person, who owns a 33.33% interest in the entity and has effective voting and disposition control, while disclaiming beneficial ownership beyond any pecuniary interest.

Positive

  • None.

Negative

  • None.
Insider Yaacov-Garbeli Dana
Role Chief Financial Officer
Type Security Shares Price Value
Grant/Award Ordinary Shares, par value NIS 0.0000769 per share 58,394 $0.00 --
Holdings After Transaction: Ordinary Shares, par value NIS 0.0000769 per share — 171,441 shares (Indirect, By A2Z Counseling Ltd.)
Footnotes (1)
  1. Represent a grant of stock-settled restricted stock units. This grant of stock-settled restricted stock units was approved by the Board of Directors (the "Board") of Entera Bio Ltd. (the "Company") on May 7, 2026. This grant was awarded to the Reporting Person in lieu of a cash bonus the Reported Person was otherwise entitled to. The restricted stock units vest ratably on a quarterly basis over a one-year period that began on May 1, 2026. These shares are owned by A2Z Counseling Ltd. of which the reporting person owns a 33.33% interest and has effective control over voting and disposition of the shares. The reporting person disclaims beneficial ownership of the securities held by A2Z Counseling Ltd., except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
RSU grant size 58,394 units Stock-settled restricted stock units granted on May 7, 2026
Shares after transaction 171,441 shares Ordinary shares indirectly held by A2Z Counseling Ltd. following grant
Ownership interest in A2Z Counseling Ltd. 33.33% Reporting person’s ownership stake in the holding entity
Vesting schedule One year, quarterly RSUs vest ratably on a quarterly basis over one year from May 1, 2026
Grant price per share $0.0000 Reported transaction price per share for the RSU grant
restricted stock units financial
"Represent a grant of stock-settled restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
stock-settled restricted stock units financial
"This grant of stock-settled restricted stock units was approved by the Board..."
pecuniary interest financial
"except to the extent of her pecuniary interest therein, if any..."
beneficial ownership financial
"The reporting person disclaims beneficial ownership of the securities held..."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Section 16 of the Securities Exchange Act of 1934 regulatory
"for purposes of Section 16 of the Securities Exchange Act of 1934, as amended..."
A provision of federal securities law that requires company insiders—directors, officers and large shareholders—to publicly report their stock holdings and trades and to surrender any “short-swing” profits from purchases and sales within a six-month window. It acts like a rule that forces leaders to announce their trades and prevents quick buy-sell windfalls, giving investors transparency into insider activity and reducing opportunities for unfair gain.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Yaacov-Garbeli Dana
(Last)(First)(Middle)
KIRYAT HADASSAH
MINRAV BUILDING, 5TH FLOOR
(Street)
JERUSALEM9112002
(City)(State)(Zip)
ISRAEL
(Country)		2. Issuer Name and Ticker or Trading Symbol
Entera Bio Ltd. [ ENTX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares, par value NIS 0.0000769 per share05/07/2026A58,394A$0(1)171,441IBy A2Z Counseling Ltd.(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represent a grant of stock-settled restricted stock units. This grant of stock-settled restricted stock units was approved by the Board of Directors (the "Board") of Entera Bio Ltd. (the "Company") on May 7, 2026. This grant was awarded to the Reporting Person in lieu of a cash bonus the Reported Person was otherwise entitled to. The restricted stock units vest ratably on a quarterly basis over a one-year period that began on May 1, 2026.
2. These shares are owned by A2Z Counseling Ltd. of which the reporting person owns a 33.33% interest and has effective control over voting and disposition of the shares. The reporting person disclaims beneficial ownership of the securities held by A2Z Counseling Ltd., except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
/s/ Dana Yaacov-Garbeli05/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Entera Bio (ENTX) report for its CFO?

Entera Bio reported a grant of 58,394 stock-settled restricted stock units to A2Z Counseling Ltd., an entity associated with CFO Dana Yaacov-Garbeli. This equity award was provided instead of a cash bonus and relates to the company’s ordinary shares, vesting over one year.

How are the new Entera Bio (ENTX) restricted stock units structured?

The 58,394 units are stock-settled restricted stock units that convert into ordinary shares upon vesting. They vest ratably on a quarterly basis over a one-year period that began on May 1, 2026, aligning compensation with the company’s equity performance over that timeframe.

Why did Entera Bio (ENTX) grant RSUs instead of a cash bonus?

The filing states the restricted stock units were awarded to the reporting person in lieu of a cash bonus she was otherwise entitled to receive. This approach shifts part of compensation into equity, tying value directly to Entera Bio’s share performance rather than immediate cash payment.

Who holds the Entera Bio (ENTX) shares from this Form 4 transaction?

The shares related to this transaction are held by A2Z Counseling Ltd., which now holds 171,441 ordinary shares. The reporting person owns a 33.33% interest in A2Z Counseling Ltd. and has effective control over voting and disposition, while disclaiming beneficial ownership beyond her pecuniary interest.

How does the Entera Bio (ENTX) CFO’s indirect ownership work through A2Z Counseling Ltd.?

The CFO’s interest is indirect, through a 33.33% stake in A2Z Counseling Ltd. The entity owns the shares, and she has effective control over voting and disposition. She formally disclaims beneficial ownership except to the extent of any pecuniary interest arising from her ownership in the entity.